Omalizumab in children with severe allergic disease: a case series

• Main Authors: Giuseppe Crisafulli (Author), Lucia Caminiti (Author), Fernanda Chiera (Author), Stefania Arasi (Author), Giuseppina Salzano (Author), Ilenia Panasiti (Author), Andrea Barbalace (Author), Giovanni Battista Pajno (Author)
• Format: Book
• Published: BMC, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Currently, severe allergic asthma and food allergy in children represent an important public health problem with medical, psychosocial and economic impacts. Omalizumab is a humanized monoclonal anti-IgE antibody, approved for refractory allergic asthma and chronic urticaria. It h...